Delivery Order SPE2DB25D3108-SPE2DB25FPDYT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,374.22 to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (2.5 mL) on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.12 to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,896.43 to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitive award utilizes firm fixed price pricing with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lumigan 0.01% eye drops in 5mL quantities under a firm fixed price contract. The award, issued on August 19, 2025, carries a ceiling value of $2,108.68 with an ultimate completion date of August 20, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a $2,121.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml), with an ultimate completion date of August 18, 2025. This contract represents a non-set-aside competitive award and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,768.84 to AmerisourceBergen Drug Corp for the supply of Lumigan 0.01% eye drops (5ml) on July 15, 2025, with an ultimate completion date of July 16, 2025. This firm fixed-price contract represents a non-set-aside competitive award and is classified as a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $2,210.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5mL) on June 6, 2025, with an ultimate completion date of June 9, 2025. The order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $3,202.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561772066 Lumigan 0.01% eye drops. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order from August 10-11, 2023 is under an existing DLA contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. As the prime and parent company, Amerisourcebergen Corporation will fulfill the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at two hundred twenty-three thousand one hundred ten dollars to Amerisourcebergen Drug Corporation for the supply of Lumigan 0.01% eye drops. Under this contract, Amerisourcebergen will deliver 2.5mL bottles of the ophthalmic solution to a location in Conshohocken, Pennsylvania by September 15, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of LUMIGAN 0.01% eye drops. The $4,409.48 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to provide a comprehensive range of pharmaceutical...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDYTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lumigan 0.01% eye drops in 7.5ml quantities, with a ceiling value of $2,796.39. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is scheduled for completion by September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The Lumigan eye drops delivery fulfills the Defense Health Agency's pharmaceutical supply needs as part of the company's extensive portfolio of brand-name and generic medications, vaccines, and specialized medical commodities distributed through the DLA's global pharmaceutical support network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/16/25 |